Spots Global Cancer Trial Database for Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
Official Title: Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia
Study ID: NCT03035344
Interventions
Study Description
Brief Summary: Study of the intermediate metabolism in children diagnosed with ALL compared to healthy matched controls.
Detailed Description: The primary cause of this study is to investigate the changes that ALL may cause to the metabolome of pediatric patients, in order to better understand its mechanism of action and target metabolic pathways for potential therapies.
Keywords
Eligibility
Minimum Age: 1 Month
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Aristotle University of Thessaloniki, Thessaloniki, , Greece
Contact Details
Name: Athanassios Evangeliou, Prof
Affiliation: Aristotle University Of Thessaloniki
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
